The Scientist

» clinical trials and developmental biology

Most Recent

image: Latest in Heart Stem Cell Debate

Latest in Heart Stem Cell Debate

By | October 26, 2015

Given the right environment, cKit+ cells from the mouse heart can develop into new cardiac muscle, according to a study.

0 Comments

image: Stem Cell Therapy In Utero

Stem Cell Therapy In Utero

By | October 13, 2015

An upcoming clinical trial aims to correct for a disease of fragile bones in affected babies before they are born.

0 Comments

image: Gut Bacteria Linked to Asthma Risk

Gut Bacteria Linked to Asthma Risk

By | October 1, 2015

Four types of gut bacteria found in babies’ stool may help researchers predict the future development of asthma.

0 Comments

image: Sex on the Brain

Sex on the Brain

By | October 1, 2015

Masculinization of the developing rodent brain leads to significant structural differences between the two sexes.

1 Comment

image: Sex Differences in the Brain

Sex Differences in the Brain

By | October 1, 2015

How male and female brains diverge is a hotly debated topic, but the study of model organisms points to differences that cannot be ignored.

27 Comments

image: Duke Cardiologist Tapped to Lead FDA

Duke Cardiologist Tapped to Lead FDA

By | September 17, 2015

The Obama administration has nominated Robert Califf, a researcher who conducted large clinical trials, as the next person to head the country’s drug approval agency.

0 Comments

image: The Sounds of Silence

The Sounds of Silence

By | September 1, 2015

Science-based tinnitus therapeutics are finally coming into their own.

3 Comments

image: Whaling Specimens, 1930s

Whaling Specimens, 1930s

By | September 1, 2015

Fetal specimens collected by commercial whalers offer insights into how whales may have evolved their specialized hearing organs.

0 Comments

image: Q&A: Placental Ponderings

Q&A: Placental Ponderings

By | August 27, 2015

Biologist Christopher Coe answers readers’ questions about the prescient organ.

0 Comments

image: Novartis Buys Rights to GSK MS Drug for $1 Billion

Novartis Buys Rights to GSK MS Drug for $1 Billion

By | August 24, 2015

The multiple sclerosis treatment has yet to be tested in Phase 3 clinical trials.

0 Comments

Popular Now

  1. Students Study Their Own Microbiomes
  2. Single Bacterial Species Improves Autism-Like Behavior in Mice
  3. Illustrating #FieldworkFails
  4. Transmissible Cancers Plague Mollusks
Biosearch Technologies